The devastating consequences of mucopolysaccharidosis II (MPS II), also called Hunter syndrome, may soon become preventable ...

Written feedback from FDA pre-NDA meeting includes a recommendation to conduct a second Phase 3 trial to generate additional ...

From the self-watching self to the predicting brain, explore 12 neuroscience-backed perspectives on consciousness. Discover ...

It could be worse,” “Everything happens for a reason, “At least you…”, “What doesn’t kill us makes us stronger” and other ...

Tividenofusp alfa treatment showed reduction and normalization in key disease biomarkers, stabilization or improvement in clinical endpoints including adaptive behavior, cognition and hearing, and ...

A new device called Barostim is helping heart failure patients at Christ Hospital in Cincinnati live more normal lives ...

New Drug Application (NDA) submission on track for January 2026 NEW YORK, Dec. 31, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in ...

A missing brain molecule may be disrupting neural wiring in Down syndrome, according to new research. Replacing it in adult mice rewired brain circuits and improved brain flexibility, challenging the ...

Studying one of the simplest animals, Stanford's Prakash Lab uncovered how it folds itself into complex shapes—revealing new ...

Vanda Pharmaceuticals received FDA approval for Nereus for motion sickness, and its shares offer upside potential into 2026 ...

The humble planarian flatworm can regrow its brain. Here’s how this tiny animal will have you rethinking everything you thought you knew about memory.